Survival after radical prostatectomy for clinically localised prostate cancer: A population-based study

BJU International

Volumn 113, Issue 4, 2014, Pages 541-547

  Røder, Martin Andreas ^a   Brasso, Klaus ^a   Christensen, Ib Jarle ^b   Johansen, Jørgen ^c   Langkilde, Niels Christian ^d   Hvarness, Helle ^a   Carlsson, Steen ^e   Jakobsen, Henrik ^f   Borre, Michael ^g   Iversen, Peter ^a  

^a University of Copenhagen   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c REGIONAL HOSPITAL WEST JUTLAND   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

cause of death; localised prostate cancer; radical prostatectomy; survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FOLLOW UP; GLEASON SCORE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR; SURVIVAL RATE;

CAUSE OF DEATH; LOCALISED PROSTATE CANCER; RADICAL PROSTATECTOMY; SURVIVAL;

AGED; DENMARK; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84896355042     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12065     Document Type: Article

References (29)

1. Vickers A, Bennette C, Steineck G, et al. Individualized estimation of the benefit of radical prostatectomy from the scandinavian prostate cancer group randomized trial. Eur Urol 2012; 62: 204-209
2. Ploussard G, Azancot V, Nicolaiew N, et al. The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core number. BJU Int 2010; 106: 1293-1297
3. Finne P, Fallah M, Hakama M, et al. Lead-time in the European Randomised Study of Screening for Prostate Cancer. Eur J Cancer 2010; 46: 3102-3108
4. Albertsen PC, Hanley JA, Barrows GH, et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005; 97: 1248-1253
5. Outzen M, Brasso K, Martinussen N, et al. Prostate cancer in Denmark 1978-2009. Acta Oncol 2012; [Epub ahead of print]
6. Mukai TO, Bro F, Pedersen KV, Vedsted P,. [Use of prostate-specific antigen testing]. Ugeskr Laeger 2010; 172: 696-700
7. Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012; 61: 1079-1092
8. Brasso K, Ingimarsdottir IJ, Thomassen L, Friis S, Iversen P,. [Prostate cancer in Denmark 1943-2002]. Ugeskr Laeger 2007; 169: 129-132
9. Bray F, Klint A, Gislum M, et al. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol 2010; 49: 644-654
10. Heggestad T, Jonsson PM, Danneskiold-Samsoe B, Leisti S,. [Prostate cancer in Scandinavia. Variations in practice and attitude to radical treatment]. Nord Med 1993; 108: 104-106
11. Wehrberger C, Berger I, Willinger M, Madersbacher S,. Radical prostatectomy in Austria from 1992 to 2009: an updated nationwide analysis of 33 580 cases. J Urol 2012; 187: 1626-1631
12. Etzioni R, Mucci L, Chen S, Johansson JE, Fall K, Adami HO,. Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden. Clin Cancer Res 2012; 18: 6742-6747
13. Sobin LH,. TNM, sixth edition: new developments in general concepts and rules. Semin Surg Oncol 2003; 21: 19-22
14. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL,. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242
15. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974
16. Montorsi F, Wilson TG, Rosen RC, et al. Best Practices in Robot-assisted Radical Prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol 2012; 62: 368-381
17. Boorjian SA, Eastham JA, Graefen M, et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 2012; 61: 664-675
18. Roder MA, Berg KD, Gruschy L, Brasso K, Iversen P,. First danish single-institution experience with radical prostatectomy: biochemical outcome in 1200 consecutive patients. Prostate Cancer 2011; 2011: 236357
19. Stephenson AJ, Kattan MW, Eastham JA, et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 2009; 27: 4300-4305
20. Veenema RJ, Gursel EO, Lattimer JK,. Radical retropubic prostatectomy for cancer: a 20-year experience. J Urol 1977; 117: 330-331
21. Gerber GS, Thisted RA, Scardino PT, et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 1996; 276: 615-619
22. Qi P, Tsivian M, Abern MR, et al. Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml. Urol Oncol 2012; [Epub ahead of print]. doi: 10.1016/j.urolonc.2012.06.003
23. Thellenberg C, Malmer B, Tavelin B, Gronberg H,. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 2003; 169: 1345-1348
24. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364: 1708-1717
25. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203-213
26. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT,. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J Urol 2002; 167: 528-534
27. Schmitges J, Trinh QD, Bianchi M, et al. The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy. Int Urol Nephrol 2012; 44: 799-806
28. Vickers A, Savage C, Bianco F, et al. Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center. Eur Urol 2011; 59: 317-322
29. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML,. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol 2008; 179: 1354-1360